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Introduction: The goal of the current study was to investigate the effect of aging on the development of
endothelial dysfunction in a murine model of sepsis, and to compare it with the effect of genetic deficiency of the
endothelial isoform of nitric oxide synthase (eNOS).
Methods: Cecal ligation and puncture (CLP) was used to induce sepsis in mice. Survival rates were monitored and
plasma indices of organ function were measured. Ex vivo studies included the measurement of vascular function in
thoracic aortic rings, assessment of oxidative stress/cellular injury in various organs and the measurement of
mitochondrial function in isolated liver mitochondria.
Results: eNOS deficiency and aging both exacerbated the mortality of sepsis. Both eNOS-deficient and aged mice
exhibited a higher degree of sepsis-associated multiple organ dysfunction syndrome (MODS), infiltration of tissues
with mononuclear cells and oxidative stress. A high degree of sepsis-induced vascular oxidative damage and
endothelial dysfunction (evidenced by functional assays and multiple plasma markers of endothelial dysfunction)
was detected in aortae isolated from both eNOS−/− and aged mice. There was a significant worsening of
sepsis-induced mitochondrial dysfunction, both in eNOS-deficient mice and in aged mice. Comparison of the
surviving and non-surviving groups of animals indicated that the severity of endothelial dysfunction may be a
predictor of mortality of mice subjected to CLP-induced sepsis.
Conclusions: Based on the studies in eNOS mice, we conclude that the lack of endothelial nitric oxide production,
on its own, may be sufficient to markedly exacerbate the severity of septic shock. Aging markedly worsens the
degree of endothelial dysfunction in sepsis, yielding a significant worsening of the overall outcome. Thus,
endothelial dysfunction may constitute an early predictor and independent contributor to sepsis-associated MODS
and mortality in aged mice.* Correspondence: szabocsaba@aol.com
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Sepsis, a life-threatening systemic inflammatory disease af-
fects nearly 700,000 people annually in the United States.
Severe sepsis occurs in one quarter of all intensive care
unit (ICU) admissions and accounts for up to half of ICU
bed days. Sepsis is associated with fatality rates of 20 to
40%. Sepsis-related health care costs amount to $17
billion/year in the United States alone. The frequency of
sepsis is increasing by >5% per year, in excess of the
growth and aging of our population. The outcome of sep-
sis is dramatically worse in older people: age alone is an
independent predictor of mortality in sepsis [1,2].
Although the development of endothelial dysfunction
is well established in various forms of shock, both in
preclinical models [3-9] and in patients [10-14], to our
knowledge, it has not been previously investigated whether
endothelial dysfunction associated with aging worsens the
outcome and increases mortality rates of septic shock.
Thus, the purpose of the current study was to investigate,
in a murine model of cecal ligation and puncture-induced
septic shock, whether aging increases the severity of endo-
thelial dysfunction, leading to a worsening of oxidative
stress, tissue inflammation and, ultimately, multiple organ
dysfunction syndrome (MODS) and death. Our experi-
mental approach included a comparison of the effect of
aging on the outcome of sepsis to the effect of complete
deficiency of endothelial nitric oxide synthase (eNOS),
in order to start exploring the possibility that endothe-
lial dysfunction may be a potential contributor to mor-
tality and MODS in aging animals subjected to sepsis.
Materials and methods
Animals
Male mice homozygous for the Nos3tm1Unc targeted muta-
tion (eNOS−/−) on a C57BL6 background were obtained
from The Jackson Laboratory, Bar Harbor, ME, USA (strain
name: B6.129P2-Nos3tm1Unc/J; stock number: 002684).
Male C57BL/6 mice (six to eight weeks of age) were used
as wild-type controls (Jackson stock number: 000664).
Aged (24 months) C57BL/6 mice were obtained from col-
onies of the National Institute on Aging. Animals were kept
in a 12 h/12 h light/dark cycle at 21 to 23°C with free access
to a standard chow diet.
Cecal ligation and puncture (CLP)
Acute sepsis was induced in mice by cecal ligation and
puncture (CLP) as previously described [15] with modifi-
cations [16]. Briefly, mice were anesthetized by ketamine/
xylazine cocktail (intraperitoneal (i.p.)), the abdomen was
shaved, wiped with 70% isopropanol and a midline ab-
dominal incision (1 to 2 cm) was performed. The cecum
was exteriorized, ligated with a sterile silk suture 1 cm
from the tip and double punctured with a 20-gauge nee-
dle. The cecum was squeezed to assure expression of asmall amount of fecal material and was returned to the
abdominal cavity. The incision was closed with auto-clips
and kept clean by povidone-iodine (Betadine). Mice were
resuscitated with i.p. injection of 1 ml of lactated Ringer’s
solution. Sham-operated mice were treated as described
above with the exception for the ligation and puncture
of the cecum. Pain was prevented by buprenorphine
(0.1 mg/kg; subcutaneous (s.c.) 30 minutes before sur-
gery and every 12 hours thereafter). For the survival
study, mice were constantly monitored for 48 hours.
Mice that survived this period of time were euthanized
by cervical dislocation. In a separate set of studies, mice
were sacrificed 12 hours following CLP by opening the
chest cavity with an incision in the diaphragm. A sample
of whole blood was collected for analysis of organ func-
tion using a comprehensive metabolic panel. Aortae
were isolated and assessed for endothelial function. Fi-
nally, major organs were snap frozen and kept at −80°C
until use. All animal procedures described in this study
have been approved by the University of Texas Medical
Branch Institutional Animal Care and Use Committee.
Complete metabolic panel
Samples of whole blood were collected from septic mice,
placed in lithium-heparin tubes and immediately processed
for quantitative determinations of alanine aminotransferase
(ALT), albumin (ALB), alkaline phosphatase (ALP), amylase
(AMY) total calcium (Ca2+), creatinine (CRE), glucose
(GLU), phosphorus (PHOS), potassium (K+), sodium (Na+),
total bilirubin (TBIL), total protein (TP), and urea nitrogen
(BUN) as described [16] by a VetScan Chemistry Analyzer
(Abaxis, Union City, CA, USA) using the VetScan Compre-
hensive Diagnostic Profile reagent rotor.
Detection of plasma markers of cardiovascular disease
(CVD panel)
Blood from CLP or sham-operated mice was collected
in K2EDTA blood collection tubes and centrifuged at
4°C for 15 minutes at 2,000xg within 30 minutes of collec-
tion. Plasma was isolated, aliquoted and stored at −80°C
until use. The EMDMillipore’s MILLIPLEX™ MAPMouse
CVD Magnetic Bead Panel 1 kit was used for the simul-
taneous quantification of the following analytes: sE-
Selectin, sICAM-1, Pecam-1, sP-Selectin, PAI-1 total,
proMMP-9, and thrombomodulin (Merck Millipore,
Darmstadt, Germany). Luminex uses proprietary tech-
niques to internally color code microspheres with two
fluorescent dyes and to create distinctly colored bead
sets of 500 5.6 μm polystyrene microspheres or 80
6.45 μm magnetic microspheres, each of which is coated
with a specific capture antibody. After an analyte from a
test sample is captured by the bead, a biotinylated
detection antibody is introduced. The reaction mixture
is then incubated with streptavidin-phycoerythrin (PE)
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reaction on the surface of each microsphere. The Lumi-
nex instrument acquires and analyze data using the
Luminex xMAP fluorescent detection method and the
Luminex xPONENT™ acquisition software (Thermo Fisher
Scientific, Waltham, MA, USA).Isolated mouse aortic ring assay
Thoracic aortae were isolated from mice 12 hours follow-
ing CLP or sham procedures. Aortic rings (approximately
2 mm in length) were placed in 5 ml organ baths filled
with oxygenated (95% O2 to 5% CO2) Krebs-Henseleit
solution at 37°C, were mounted onto isometric force
transducers (Kent Scientific, Minneapolis, MN, USA), and
connected to a PowerLab data acquisition system (AD In-
struments, Dunedin, New Zealand) for the detection of
isometric tension, as described [17]. Aortic rings were
allowed to equilibrate for 45 minutes under a resting ten-
sion of 1.5 g and subsequently contracted with phenyleph-
rine (PE; 1 μM). Once a plateau was reached, cumulative
concentration response curves to acetylcholine (Ach) or
to the nitric oxide (NO) donor sodium nitroprusside
(SNP) were performed in order to assess the smooth
muscle relaxation in response to endothelium-derived or
exogenously applied NO. The experiments were repeated
in at least four aortic rings, each from a different mouse.Detection of protein oxidation by the OxyBlot assay
Immunodetection of protein carbonyl groups (index of
oxidative stress) was performed in tissue homogenates
from thoracic aortas collected from mice undergoing
12 hours of severe sepsis, using the OxyBlot kit (Millipore)
as described [18]. Protein carbonyl groups were deriva-
tized with 2, 4-dinitrophenylhydrazine (DNPH) generating
a stable dinitrophenylhydrazone (DNP) product immu-
nodetected by specific anti-DNP antibodies. Following
derivatization of the aortic tissue homogenates with
DNPH, 20 μg of protein extracts were subjected to
SDS-polyacrylamide gel electrophoresis (SDS-PAGE)
using NuPAGE Novex 4% to 12% Bis-Tris Midi gels
(Invitrogen, Thermo Fisher Scientific, Carlsbad, CA, USA).
After electrophoresis, the proteins were transferred to a
PVDF membrane. Membranes were then blocked in Start-
ing Block T20 (TBS) blocking buffer (Thermo Fisher
Scientific) and incubated with a rabbit anti-DNP primary
antibody (1:500) provided by the manufacturer. The pri-
mary antibody was detected using an OxyBlot supplied
horseradish peroxidase (HRP)-conjugated anti-rabbit im-
munoglobulin (Ig)G secondary antibody. Immunoreactivity
was visualized by chemiluminescent detection. The Oxy-
blot method produces a smear-like blot, indicative of the
oxidative modification of multiple proteins of different mo-
lecular weights. Blots were scanned and a densitometricanalysis was performed on the totality of the modified pro-
teins using NIH Image J software.Determination of tissue lipid peroxidation: malondialdehyde
assay
Tissue malondialdehyde (MDA) levels, an index of cellu-
lar injury/oxidative stress, were detected as described
[16] in aorta, liver and mesenteric vascular bed homoge-
nates from mice subjected to 12 hours of CLP-induced
sepsis, using a fluorimetric MDA-specific lipid peroxida-
tion assay kit (Enzo Life Sciences, Farmingdale, NY, USA)
according to the manufacturer’s instructions. The assay is
based on the BML-AK171 method in which two mole-
cules of the chromogenic reagent N-methyl-2-phenylin-
dole (NMPI) react with one molecule of MDA at 45°C to
yield a stable carbocyanine dye with a maximum absorp-
tion at 586 nm.Myeloperoxidase activity assay
Myeloperoxidase activity was measured in aorta, liver
and mesenteric vascular bed extracts from wild-type,
eNOS−/− and aged mice subjected to 12 hours of CLP-
induced severe intra-abdominal sepsis, as described [16]
using a commercially available myeloperoxidase (MPO)
fluorometric detection kit (Enzo Life Sciences). The assay
utilizes a non-fluorescent detection reagent, which is oxi-
dized in the presence of hydrogen peroxide and MPO to
produce its fluorescent analog. The fluorescence is mea-
sured at excitation wavelength of 530 to 571 nm and emis-
sion wavelength of 590 to 600 nm.Isolation of liver mitochondria
The IV lateral liver lobes were harvested from mice sub-
jected to sham operation or CLP at 12 hours. Mitochon-
dria from livers were isolated by differential centrifugation
as described [19]. In brief, livers were homogenized on ice-
cold mitochondrial isolation buffer (MSHE-BSA, pH 7.2)
composed of 210 mM mannitol, 70 mM sucrose, 5 mM
HEPES, 1 mM EGTA, and 0.5% (w/v) fatty acid-free BSA
using a drill-driven teflon glass homogenizer. Homoge-
nates were centrifuged at 600 g for 10 minutes at (4°C).
Following centrifugation, the lipid phase was carefully re-
moved by aspiration and the remaining supernatant was
decanted to a separate tube and centrifuged at 10,000 g for
10 minutes (4°C). The supernatant fraction was removed,
the pellet was suspended in MSHE-BSA, and the centrifu-
gation procedure was repeated two more times. Finally, the
pellet was resuspended in a small volume (approximately
100 μl) of MSHE-BSA. Total protein was determined using
the Pierce BCA Protein Assay Reagent (Thermo Fisher
Scientific). Mitochondrial preparations were used for bio-
energetic analysis within 1 to 3 hours.
Figure 1 Time course of survival rates in young, aged and
eNOS−/− mice subjected to CLP. Mice were subjected to acute
sepsis by CLP as described in Methods and constantly monitored for
48 hours. Death events were annotated and the Kaplan-Meier
estimate was used to compute the survival rates over time. Please
notice that by 24 hours the eNOS-deficient mice showed the
highest mortality rate (about 70%). At this time there was 40%
mortality in the aged mice while no mortality in the wild-type
control group (young mice). By 24 to 36 hours all the eNOS−/− mice
died, the mortality of the aged mice increased to about 60% while
all the young mice survived. By 48 hours, the survival rates of the
aged mice and the young mice were 20% and 50% respectively.
Sham-operated mice showed no mortality in the 48-hour time frame
(not shown) (P = 0.008 eNOS−/− vs. young and P = 0.024 aged vs.
young; n = 12/group). CLP, cecal ligation and puncture; eNOS,
endothelial isoform of nitric oxide synthase.
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The XF24 Extracellular Flux Analyzer (Seahorse Biosci-
ences, North Billerica, MA, USA) was used to measure
mitochondrial bioenergetic function, as described [19].
Respiration by the mitochondria (10 μg/well) was se-
quentially measured in a coupled state with substrate
present (basal respiration, State 2), followed by State 3
(phosphorylating respiration, in the presence of adeno-
sine 5′-diphosphate sodium salt (ADP) and substrate),
State 4 (non-phosphorylating or resting respiration) fol-
lowing conversion of ADP to adenosine triphosphate
(ATP), State 4o, induced with the addition of oligomycin.
Next, maximal uncoupler-stimulated respiration (State
3u) was detected by the administration of the uncoup-
ling agent carbonylcyanide-4-trifluorometh-oxyphenyl-
hydrazone (FCCP). At the end of the experiment the
Complex III inhibitor, antimycin A was applied to com-
pletely shut down the mitochondrial respiration. This
‘coupling assay’ examines the degree of coupling between
the electron transport chain (ETC.), and the oxidative
phosphorylation (OXPHOS), and can distinguish between
ETC. and OXPHOS with respect to mitochondrial func-
tion/dysfunction. In a second set of studies, electron
flow experiments were conducted. This method allows
the functional assessment of selected mitochondrial
complexes together in the same time frame. Mitochon-
drial electron transport was stimulated by the addition
of pyruvate/malate (10 mM/2 mM, respectively, in order
to enable the activity of all complexes); with succinate
(10 mM, in the presence of the Complex I inhibitor
rotenone, 2 μM, in order to direct the electron flow ex-
clusively through complexes II, III and IV) or with the
artificial substrates ascorbate/TMPD (10 mM/100 μM,
respectively, in the presence of the Complex III inhibi-
tor antimycin at 4 μM, in order to selectively activate
Complex IV) (3).
Statistical analysis
Data are shown as mean ± SEM. One-way and two-way
ANOVA with Bonferroni’s multiple comparison test were
used to detect differences between groups. Statistical cal-
culations were performed using Graphpad Prism 5 ana-
lysis software (GraphPad Software, La Jolla, CA, USA).
Results
eNOS deficiency and aging both exacerbate the mortality
of sepsis
To determine whether mice exhibited an eNOS deficiency-
and/or an age-associated vulnerability to sepsis, we com-
pared mortality rates of eNOS−/− and aged (24 months)
versus young mice (C57BL/6, approximately two months
of age) in response to CLP. Mortality was assessed every
12 hours for two days. At the end of the second day, the
mice that survived were sacrificed by opening the chestcavity under deep anesthesia. In our model of sepsis,
approximately 70% of the eNOS deficient mice died by
24 hours, showing the highest mortality rate among the
animal groups studied (Figure 1). At the same time, there
was 40% mortality in the aged mice. In contrast, no
mortality was detected in the wild-type control group.
By 48 hours, the survival rates of the aged mice and the
young were 20% and 50% respectively; none of the
eNOS−/− mice used in the study survived to 48 hours.
eNOS deficiency and aging both induce a worsening of
sepsis associated-multiple organ dysfunction (MOD),
tissue inflammation and oxidative stress
In a different set of experiments, tissues and blood were
harvested from eNOS−/−, aged and young mice subjected
to 12 hours of CLP. A complete metabolic panel for de-
tection of plasma markers of organ injury was performed
through the VetScan Chemistry Analyzer (Table 1). The
analysis revealed a slight trend of CLP-induced increase
of the liver injury markers ALT and ALP and the pancre-
atic injury marker AMY in wild-type mice. Significantly
higher increases were noted in the same parameters, both
in the aged and eNOS−/− mice. Blood urea nitrogen (BUN),
phosphorus (PHOS) and creatinine (CRE) levels (index of
renal and hepatic failure) increased in the eNOS−/− and
aged mice but remained in the standard range in the young
wild-type septic young mice. Analysis of tissue oxidative
Table 1 Comprehensive metabolic panel in mice subjected to CLP
SHAM CLP
Young Aged eNOS−/− Young Aged eNOS−/−
Mean SEM N Mean SEM N Mean SEM N Mean SEM N Mean SEM N Mean SEM N
ALB (g/l) 30.20 1.32 5 30.40 1.12 5 32.20 0.73 5 22.00* 4.16 5 22.00* 1.53 5 17.00* 0.58 5
ALP (U/l) 58.20 4.31 5 67.60 7.22 5 69.40 1.36 5 82.00* 13.87 5 102.33*# 25.34 5 96.00*# 2.89 5
ALT (U/l) 29.80 2.52 5 41.20 6.05 5 47.00 2.63 5 50.00* 1.73 5 77.00*# 7.51 5 89.67*# 21.67 5
AMY (U/l) 869.60 38.09 5 943.80 38.30 5 915.00 41.37 5 1117.00* 117.60 5 1346.67*# 174.79 5 907.00 201.53 5
TBIL (μM) 4.79 0.34 5 5.47 0.34 5 5.47 0.34 5 4.67 0.33 5 4.33 0.67 5 5.33 0.67 5
BUN (mM) 7.43 0.21 5 7.71 0.54 5 10.21 0.14 5 10.23 1.05 5 25.93*# 1.79 5 28.90*# 1.40 5
Ca2+ 2.20 0.01 5 2.29 0.06 5 2.28 0.05 5 1.86 0.07 5 2.12 0.13 5 2.11 0.02 5
PHOS (mM) 1.87 0.10 5 2.32 0.09 5 2.02 0.12 5 2.66* 0.42 5 4.57*# 0.23 5 4.78*# 0.64 5
CRE (μM) 19.45 1.77 5 31.82 6.00 5 24.75 5.15 5 19.67 1.67 5 25.67*# 7.67 5 27.33*# 9.3305
GLU (mM) 12.90 0.50 5 12.38 1.76 5 12.28 1.27 5 10.17 3.12 5 8.50 0.89 5 11.80 3.85 5
Na+ (mM) 141.20 0.97 5 147.00 1.64 5 144.20 1.69 5 150.00 3.51 5 149.33 1.20 5 152.33 3.53 5
K+ (mM) 5.34 0.23 5 6.66 0.26 5 6.00 0.48 5 5.40 0.96 5 5.80 0.25 5 8.87 0.52 5
TP (g/l) 48.80 0.80 5 49.80 2.00 5 47.80 0.70 5 35.33 3.38 5 27.63 11.87 5 35.67 1.76 5
GLOB (g/l) 18.20 1.00 5 19.60 1.40 5 14.80 0.20 5 13.67 1.67 5 21.00 5.00 5 18.67 2.33 5
Determinations of alanine aminotransferase (ALT), albumin (ALB), alkaline phosphatase (ALP), amylase (AMY) total calcium (CA2+), creatinine (CRE), glucose (GLU),
phosphorus (PHOS), potassium (K+), sodium (NA+), total bilirubin (TBIL), total protein (TP), globulin (GLOB) and urea nitrogen (BUN) were performed by VetScan
Chemistry Analyzer (Abaxis) on 100 μl of heparinized whole blood collected from young, aged and eNOS-deficient mice subjected to 12 hours of severe sepsis
(CLP) or sham operation. *(P <0.05) vs. corresponding sham-operated group. #(P <0.05) vs. young CLP mice (n = 5 per group). Please notice the marked degree of
multiple organ dysfunctions induced by sepsis in aged and eNOS knockout mice. CLP, cecal ligation and puncture.
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tration by the MPO activity assay were carried out in aorta,
mesenteric bed (a vascular district known to be exquisitely
abundant in endothelium and sensitive to eNOS/NO-
dependent effects on the peripheral vascular homeosta-
sis) and liver homogenates, showed an overall increase
in sepsis-induced tissue damage both by aging and by
eNOS deficiency (Figure 2).
eNOS deficiency and aging both enhance the degree of
cardiovascular oxidative damage and the degree of
endothelial dysfunction in sepsis
Plasma levels of sE-Selectin, sICAM-1, Pecam-1, sP-
Selectin, PAI-1 total, proMMP-9, and thrombomodulin
were simultaneously detected in young, aged or eNOS−/−
mice 12 hours following CLP or sham procedure (Figure 3).
Low baseline values of the markers of endothelial dys-
function were detected in sham-operated mice, grossly
unchanged within the groups. Although 12 hours is a
relatively short time to expect increased plasma levels of
sE-Selectin, sP-Selectin and Pecam-1 in septic young
mice compared to the sham group, their levels did
increase significantly in the aged and eNOS-deficient
septic mice. The analysis of the data revealed a similar
trend of increase for pro-MMP-9 and thrombomodulin.
Twelve hours of CLP induced about 15-fold increase in
both pro-MMP-9 and thrombomodulin plasma levels in
young septic mice compared to young, sham-operatedmice. More pronounced increases were detected in the
septic eNOS−/− with the septic aged mice showing the
highest levels among the groups. No statistically signifi-
cant differences were detected between young, aged and
eNOS-deficient septic mice for plasma levels of SICAM-1
and PAI-1. Detection of protein carbonyl groups, index of
oxidative damage, was performed by OxyBlot analysis of
aortae isolated from mice subjected to CLP. As shown in
Figure 4A and B, some protein carbonylation was already
detectable in wild-type septic mice, but the induction
(measured by software-assisted densitometric analysis of
the chemiluminescent signal) increased more substantially
(by about three- and two-fold, respectively) in aged mice
and eNOS-deficient mice. Dysfunction of the endothelium
during sepsis was determined by assessing the Ach-
induced vasorelaxant responses in vitro in aortic rings
precontracted with phenylephrine. As expected, aortic
rings from eNOS−/− mice were completely unable to
relax in response to Ach (Figure 4C and D). Aged mice
showed some basal level of endothelial dysfunction, as
evidenced by a shift to the right of the sigmoidal con-
centration response curve to Ach in the sham group.
CLP-induced sepsis produced a significant degree of
endothelial dysfunction, the severity of which was more
profound in the aged mice compared to the young mice
(mean LogEC50 from −7.8 to −7.5 in young mice, sham
versus CLP; mean LogEC50 from −7.3 to −6.8 in aged
mice, sham versus CLP). Moreover, both aged and eNOS-
Figure 2 Determination of lipid peroxidation and myeloperoxidase activity in aorta, mesenteric bed and liver harvested from
CLP-injured mice. Tissue malondialdehyde (MDA) levels (index of cellular injury/oxidative stress) and myeloperoxidase (MPO) activity (used as a
marker of tissue inflammation) were detected in aorta (Panel A and D), mesenteric vascular bed (Panel B and E) and liver (Panel C and F)
harvested from young, aged and eNOS−/− mice subjected to 12 hours of CLP-induced sepsis (*P <0.05 vs. young; n = 5 tissue samples were
analyzed in each group of mice). CLP, cecal ligation and puncture; eNOS, endothelial isoform of nitric oxide synthase.
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donor SNP (Figure 4E and F).
Severity of endothelial dysfunction, a predictor of
mortality in mice during sepsis
In the current model of severe sepsis, the survival rate in
the young group of mice was approximately 50% at
48 hours. In the next set of studies, we aimed to investi-
gate whether the degree of endothelial dysfunction cor-
relates with the outcome of sepsis. Mice were divided
into two groups: those that survived and those that did
not survive 48 hours of sepsis. Mice were closely moni-
tored for the 48-hour period of time and thoracic aortae
from the non-survivors were harvested at the time of
death and processed for assessment of in vitro vascular
response to endothelium-derived NO by Ach stimula-
tion. Mice that survived the 48 hours of sepsis were eu-
thanized by opening the chest cavity and the aortic ring
assay was performed subsequently. A distinct difference
of severity of endothelial dysfunction was detected be-
tween the young mice that survived and those that died(Figure 5). In a subsequent study, a similar approach was
used for the assessment and comparison of endothelial
function in survivor versus non-survivor aged mice. Since
the survival rate at 48 hours of CLP is only 80% in the case
of the aged mice, we restricted the CLP to 24 hours. Aor-
tic rings were harvested from five non-survivor mice at
the time the death was scored (see figure legend for add-
itional methodological details). The survivors were eutha-
nized 24 hours following CLP. These data indicate that
endothelial dysfunction precedes mortality and suggest
that it may be a predictor of it.
eNOS deficiency and aging both produce a worsening of
sepsis-induced mitochondrial dysfunction in sepsis
CLP caused a significant reduction of the total mitochon-
drial function based on different bioenergetic measure-
ments (‘coupling’ and ‘electron flow’ assays) in isolated
mouse liver mitochondria ex vivo (Figure 6A and B), indi-
cative of an overall, sepsis-associated impairment of mito-
chondrial function. A decrease in oxygen consumption
rate (OCR) was also noted both in sham-operated aged
Figure 3 Detection of plasma markers of cardiovascular dysfunction (CVD panel) in sham-operated or CLP-injured mice. Plasma levels of
sE-Selectin (Panel A), sP-Selectin (Panel B), Pecam-1 (Panel C), proMMP-9 (Panel D), thrombomodulin (Panel E), sICAM-1 (Panel F), and PAI-1
Total (Panel G), were simultaneously detected in young, aged or eNOS−/− mice 12 hours following sham (left three columns in each panel) or
CLP (right three columns in each panel) procedure. (*P <0.05 vs. corresponding sham-operated mice and #P <0.05 vs. young CLP; n = 5 individual
plasma samples were tested from each group of mice). CLP, cecal ligation and puncture; eNOS, endothelial isoform of nitric oxide synthase.
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mice (all in the absence of CLP). CLP, in turn, tended to
further worsen mitochondrial function in all three groups
(Figure 6C and D).
Discussion
The vasculature, under normal conditions, produces local
endothelium-dependent vasodilatory mediators, the most
important of which is nitric oxide (NO). The loss of endo-
thelial function in sepsis is known to promote impaired
local regulation of vascular responsiveness; impaired vascu-
lar autoregulation, tissue metabolism/perfusion mismatch,
increased intravascular coagulation, and platelet/neutrophil
adhesion/activation [8,20-22]. One of the principal causes
of mortality in sepsis is progressive vascular dysfunction.
As first shown over 20 years ago [3,4], and repeatedlyconfirmed by multiple studies since then [5-14], various
forms of circulatory shock are associated with the devel-
opment of endothelial dysfunction, that is an impaired
ability of the endothelial cells to produce NO. Several
lines of evidence support the view that endothelial dys-
function is a key factor in promoting coagulation abnor-
malities, multiple organ failure and mortality in sepsis
in humans, as well [9,21]. Importantly, in septic patients,
the degree of the loss of endothelium-dependent vasore-
laxant responsiveness shows a close correlation with mor-
tality [13,14,23].
Endothelial dysfunction promotes neutrophil adhesion
and infiltration into tissues, which is a key contributor
to MODS [21-27]. In addition, endothelial dysfunction in
sepsis leads to perfusion/oxygenation mismatch and co-
agulation abnormalities, culminating in mortality in sepsis
Figure 4 (See legend on next page.)
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Figure 4 Assessment of oxidative damage and endothelial dysfunction in aortas isolated from septic mice. (Panel A) Following CLP,
young, aged and eNOS−/− mice were euthanized by opening the chest cavity under deep anesthesia and the thoracic aortas were isolated.
Twenty μg of protein extracts were subjected to SDS-PAGE and derivatized protein carbonyl groups were immunodetected by OxyBlot (Merck
Millipore). Immunoreactivity was visualized by chemiluminescent detection. Blots were scanned and a densitometric analysis was performed
(Panel B) (*P <0.05 vs. young mice; n = 3). In a separate set of experiments, aortic rings (approximately 2 mm in length) were harvested from
sham-operated and CLP-injured mice, placed in 5 ml organ baths filled with oxygenated (95% O2 to 5% CO2) Krebs-Henseleit solution at
37°C and mounted onto isometric force transducers. Concentration response curves to acetylcholine (Ach) (Panel C and D) and sodium
nitroprusside (SNP) (Panel D and E) were performed on a stable phenylephrine-induced tone. Please notice the inability of the aortic rings from
eNOS−/− mice to respond to Ach stimulation. Aged mice showed a basal level of endothelial dysfunction (Panel C) (*P <0.05 vs. young). CLP
induced a shift to the right of the concentration response curve to Ach, which was more pronounced in the aged mice compared to the young
(Panel D) (mean LogEC50 from −7.797 to −7.488 in young mice; mean LogEC50 from −7.261 to −6.762 in aged mice). Increased sensitivity to
the nitric oxide (NO) donor SNP was also seen in aged and eNOS-deficient vessels (Panel E and F). CLP, cecal ligation and puncture; eNOS,
endothelial isoform of nitric oxide synthase.
Coletta et al. Critical Care 2014, 18:511 Page 9 of 15
http://ccforum.com/content/18/5/511[8,20,21]. Supplementation of NO has been shown to im-
prove the outcome of various forms of shock [24-27].
These findings support the hypothesis that impairment
of endothelium-dependent relaxations is an important
pathogenetic process in sepsis. Consequently, it has been
previously suggested [21-28] that therapeutic approachesFigure 5 Assessment of endothelial function in mice that survived or
young mice as described in Methods. Following CLP, mice were constantly
approximately 50%. Thoracic aortas from the mice that did not survive the
in 5 ml organ baths filled with oxygenated Krebs-Henseleit solution at 37°C
response to endothelium-derived nitric oxide (NO) by acetylcholine (Ach) s
non-survivors were used. The mean time of survival (or tissue harvesting) was
the chest cavity. In a sequent study, a similar approach was used for the asses
non-survivor aged mice. Since the survival rate at 48 hours of CLP is only 80%
frame. Aortic rings were harvested from five different mice. The mean time of
were euthanized 24 hours following CLP. Please note the marked degree of e
B and C). Concentration response curves to the NO donor sodium nitropruss
and the viability of the tissue preparations (Panel D). (*P <0.05 vs. correspondthat preserve endothelial function have the potential to
improve sepsis outcomes.
Even though sepsis is a disease of the aged population,
it is surprising that, as of to date, all of the published stud-
ies investigating endothelial dysfunction in sepsis have used
neonatal or young/adult animals. In other words, thedid not survive 48 hours of sepsis. CLP was performed in C57BL/6
monitored for 48 hours. In our model the survival rate at 48 hours is
48 hours of sepsis were harvested at the exact time of death, placed
and mounted onto isometric force transducers to assess for vascular
timulation. Five death events were recorded, aortic rings from the five
39 hours. Survivors were euthanized at 48 hours of sepsis by opening
sment and comparison of endothelial function in survivor versus
in the case of the aged mice, we restricted the CLP to a 24-hour time
survival (or tissue harvesting) in this group was 17 hours. The survivors
ndothelial dysfunction in the non-survivor group of animals (Panel A,
ide (SNP) were performed to ensure the integrity of the smooth muscle
ing survivors). CLP, cecal ligation and puncture.
Figure 6 Bioenergetic analysis in isolated liver mitochondria from mice subjected to sham or CLP operation. Mitochondrial respiration/
function was determined by oxygen consumption rate (OCR) utilizing the Seahorse XF24 Extracellular Flux Analyzer (Seahorse Bioscience). During
the coupling experiment in isolated mitochondria (A, C, D), the assay media contains succinate, as a complex II substrate and rotenone as a
complex I inhibitor. Sequential measurement of basal, State 2 (a), State 3 (b), State 4o (c) and the uncoupler-stimulated respiration, State 3u (d)
were performed through the sequential injections of ADP, oligomycin, FCCP and antimycin. Please note that the OCR after the addition of FCCP
(State 3u) is much higher in sham group (A). Furthermore, a significant impairment in State 3 and State 3u respirations has been detected in aged
and eNOS−/− group compared to young mice subjected to CLP intervention or the sham group (C, D). (Panel A, C, D, **P <0.01 and ***P <0.001
vs. sham or CLP-operated young mice; n = at least 4/group). The experiment in (panel B) demonstrates the electron flow activity through the
different complexes of the electron transport chain. The assay media contains pyruvate/malate as substrates of complex I, and FCCP to uncouple
the mitochondrial function. In uncoupled mitochondria all complexes can be examined individually by the sequential injection of rotenone,
succinate, antimycin and TMPD/ascorbate. All these mitochondrial toxins and substrates permit to observe 1., the function of complex I (a), 2.,
the inhibition of complex I (b), 3., the function of complex II (c), 4., the inhibition of complex II (d), 5., the activity of cytochrome C/complex IV
(e). Overall, all mitochondrial complexes show better function in mitochondria isolated from the liver of the sham group compared to the other
groups (Panel B, **P <0.01 vs. sham-operated mice; n = at least 4/group). ADP, adenosine 5′-diphosphate sodium salt; CLP, cecal ligation
and puncture; eNOS, endothelial isoform of nitric oxide synthase; FCCP, carbonylcyanide-4-trifluorometh-oxyphenylhydrazone; TMPD,
tetra-methyl-p-phenylenediamine dihydrochloride.
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have never been specifically explored in aged animals, and
all of the currently published reports on the pathogenesis
of endothelial dysfunction in sepsis are incomplete, as they
do not take into account this key aspect of the disease. The
results of the present study show that endothelial dys-
function (evidenced both by functional studies, that is
endothelium-dependent relaxation, as well as by meas-
uring multiple plasma indices of endothelial cell dys-
function) is early-onset and particularly severe in aged
mice subjected to CLP. Previous studies suggest that
aging is associated with impaired bioavailability of NO,
at least in part, due to a downregulation of endothelialeNOS expression and activity [29,30] and that mice with
genetic eNOS deficiency exhibit an accelerated cardiovas-
cular aging phenotype [31]. The present results demon-
strate that - similar to aging [32], eNOS deficiency also
exacerbates MODS and mortality in the currently used
rodent model of sepsis. In addition, both eNOS-deficient
and aged mice exhibit a higher degree of sepsis-associated
multiple organ dysfunction, tissue inflammation and
oxidative stress. Moreover, both eNOS-deficient and
aged mice exhibit a high degree of vascular oxidative
damage in CLP-induced sepsis. In addition, there is a
significant worsening of sepsis-induced mitochondrial
dysfunction, both in eNOS-deficient mice and in aged
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groups of animals indicates that the severity of endothe-
lial dysfunction may be a predictor of mortality of mice
subjected to CLP-induced sepsis. Taken together, the
current results suggest (but do not directly prove) that
endothelial dysfunction may be an independent con-
tributor as well as early predictor of MODS and mortal-
ity in sepsis.
It is worth mentioning that a recent study by Raeven
and colleagues has used a similar approach to our study
in the sense that it compared endothelial dysfunction
marker levels (PAI-1, thrombomodulin) in dying/surviving
subgroups of animals subjected to CLP (in this study, the
context was to determine if a pre-existing trauma ampli-
fies subsequent CLP outcomes). In this study, significantly
higher PAI-1 levels were found in the non-surviving septic
mice as opposed to the survivor groups, while no differ-
ences were noted with respect to thrombomodulin levels
[33]. This study also concluded that most of the PAI-1 re-
lease is not the consequence of endothelial dysfunction,
but is derived from other sources (such as the liver). Inter-
estingly, in the current study, PAI-1 was not a marker that
was exacerbated by either eNOS deficiency or by aging in
response to CLP (Figure 3) (as opposed to many other
markers of endothelial dysfunction that were exacerbated,
including thrombomodulin). When taken together, these
studies with the current report, we may conclude that
pre-existing aging or eNOS deficiency may exacerbate the
outcome of CLP via mechanisms that may (at least in
part) depend on the development of endothelial dysfunc-
tion, while the amplifying effect of pre-existing trauma
mainly involves other mechanisms.
What, then, may be the potential molecular mecha-
nisms underlying the development of endothelial dys-
function in aging animals subjected to sepsis? First of all,
there is already a 'baseline' level of endothelial dysfunction
in the aging organism. This has been well documented,
both in the absence and in the presence of additional risk
factors (for example hypertension, diabetes, smoking)
[34-38]. The causes of this dysfunction are at least
four-fold. The first factor is oxidative stress. Increased
production of reactive oxygen species ((ROS); from
mitochondrial sources as well as due to an increased ac-
tivity of NAD(P)H oxidases) is prevalent in aged blood
vessels [34-40]. The impairment of NO bioavailability in
aging is, in part, due to direct inactivation of NO by
superoxide, but this response is further aggravated by
an age-related decline in eNOS expression, reduced
availability of tetrahydrobiopterin and/or a decreased
intracellular L-arginine [34-40]. The second factor is an
enhanced activation of pathways downstream of oxida-
tive stress. Many of the adverse consequences of oxida-
tive stress are mediated via production of peroxynitrite:
a substantially enhanced cardiovascular peroxynitriteformation is present in aged blood vessels. Downstream
targets of peroxynitrite-induced cytotoxicity are mul-
tiple and include vascular poly (ADP-ribose) polymerase
(PARP) overactivation [41-44]. The third factor is a de-
pressed activity/expression of antioxidant enzymes. The
pathomechanisms of vascular aging are intimately linked
to reduced antioxidant defenses, including inhibition of
various antioxidant enzymes (for example superoxide dis-
mutase), as well as reduced levels of antioxidant factors
(for example glutathione). A central and specific compo-
nent of this attenuated antioxidant response is the inability
of the aged cells to activate Nrf2, a key master switch of
antioxidant defense in the cell [45-50]. Finally, the
fourth factor is a low-grade vascular inflammation. In
aged blood vessels, reactive oxygen/nitrogen species
(ROS/RNS)-dependent signaling induces proinflamma-
tory responses, which, then, form a positive-feedback
circle by further promoting cellular oxidative stress (for
example by activation of NAD(P)H oxidases) [51-53].
Since circulatory shock is known to activate some of
the same pathways of vascular injury as in aging, includ-
ing oxidative stress, downstream pathways of oxidant in-
jury, suppression of antioxidant defenses and vascular
(as well as systemic) inflammation [54-61], it is not en-
tirely surprising that in aged blood vessels, circulatory
shock induces an particularly severe form of endothelial
dysfunction, in which oxidative/nitrosative processes be-
come a dominant cause of the injury. Based on recent
data in various in vitro and in vivo experimental systems
[49,50] we hypothesize that this phenomenon is, to a
significant degree, due to the fact that aged blood vessels
lose their ability to activate Nrf2, and thereby they are
unable to mount proper antioxidant defenses, leading to
an increased oxidative-nitrosative stress, and hyperacti-
vation of downstream damage pathways. This, however,
remains to be further investigated in future studies.
Endothelium-derived NO plays a key role in regulation
of mitochondrial function and cellular energy balance
[62-64]. On the basis of the aforementioned studies, we
also hypothesize that the exacerbation of ROS/RNS-me-
diated responses and endothelial dysfunction are key
contributors to the development of mitochondrial dys-
function demonstrated in the current study. According
to multiple preclinical and clinical studies, mitochondrial
dysfunction (or 'cytopathic hypoxia') is a significant con-
tributor to organ dysfunction and mortality in various
forms of critical illness [65-67]; based on the current data,
we hypothesize that a suppression of endothelial NO pro-
duction may be one of the upstream/proximate causes of
this defect. It was also interesting to note that eNOS defi-
ciency, as well as aging, both produced a comparable
degree of 'baseline' suppression of mitochondrial func-
tion. Although the mechanisms responsible for these
findings remain to be further explored, we hypothesize
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acerbation of oxidative stress, which, in turn, may dam-
age mitochondrial electron transport proteins, and may
contribute to a dysfunction of the mitochondrial elec-
tron transport chain.
We realize that the current study has a number of lim-
itations. We have conducted, on one hand, a comparison
of normal young mice subjected to CLP with old mice
subjected to CLP. On the other hand, we compared sep-
tic (young) eNOS knockouts subjected to CLP to the
young wild-type mice subjected to CLP. The similarities
of the exacerbation of the response to CLP are striking,
but we admit that these similarities and parallels only
suggest (but do not prove) causality. One future experi-
ment to get closer to probing causality may consist of
the induction of CLP in aged eNOS-deficient mice; an-
other future experiment may consist of the therapeutic/
pharmacological replacement of NO in aged mice sub-
jected to CLP. We must also point out that the current
experimental design did not use antibiotics during CLP.
In the field of CLP, some investigators routinely use anti-
biotics and others do not. It appears to us that many
(but not all) investigators who are interested in basicFigure 7 Potential pathways and mechanisms underlying the enhanc
sepsis. In aged blood vessels, septic shock induces an overwhelming degr
dysfunction, which, in turn, contributes to the MODS and mortality of seps
aged endothelial cell, oxidative stress is unable to induce an appropriate ac
details. ARE, antioxidant response element; BH4, tetrahydrobiopterin, a co-f
intracellular calcium concentration; Keap1, Kelch-like erythroid cell-derived pro
organ dysfunction syndrome; NO, nitric oxide; Nrf2, nuclear factor erythroid 2pathological processes first start out with CLP models
without antibiotics, while many (but not all) investiga-
tors who are more focused on therapeutic/translational
approaches tend to use antibiotics. As the current study
was more focused on basic pathophysiological mecha-
nisms and not (yet) therapeutic interventions, we selected
a model without antibiotics for the initial set of experi-
ments. However, future follow-up studies may incorporate
antibiotics as well. Finally, additional studies in outbred
mice (as opposed to inbred mice) and comparison of the
results in male and female mice will be necessary to probe
and potentially extend the validity of the current findings.
Conclusions
Taken together, based on the results of the current study,
and based on published reports in the literature, we
propose the following working model (Figure 7) of patho-
physiological events in aged animals subjected to sepsis.
(1) In the aging organism, there is a baseline endothelial
dysfunction, which is the consequence of increased oxida-
tive stress and low-level vascular inflammation, all of
which is the consequence of 'normal' or 'physiological'
aging. (2) As part of the same processes, antioxidantement of endothelial dysfunction in aged mice subjected to
ee of oxidative damage, leading to a marked degree of endothelial
is. We hypothesize that part of the process involves the fact that in
tivation of the Nrf2/ARE pathway. Please see Discussion for additional
actor of eNOS; eNOS, endothelial isoform of NO synthase; iCa2+,
tein with CNC homology (ECH)-associated protein 1; MODS, multiple
(NF-E2)-related factor 2; PARP, poly(ADP-ribose) polymerase.
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(3) When subjected to systemic inflammation/sepsis, the
aging organism is unable to mount an appropriate antioxi-
dant defensive response. (4) At the same time, the sepsis-
induced endothelial dysfunction and the baseline-level
endothelial dysfunction, in an additive/synergistic fash-
ion, lead to a particularly severe form of endothelial
dysfunction (that is vascular NO levels are markedly
suppressed). (5) The overwhelming amount of reactive
oxidants, coupled with the low amount of antioxidant
NO, leads to a 'tipping of the balance' of the ROS/RNS
status, leading to an increased degree of oxidative protein
modifications, culminating in further endothelial dysfunc-
tion, mitochondrial injury, cellular energetic impairment,
cell death, culminating in a severe degree of multiple
organ dysfunction and high mortality. These processes
occur, at least in part, through the activation of various
positive feedback cycles of cell injury. One of these cycles
may involve an enhancement of pro-coagulation path-
ways, which are known to be markedly exacerbated in
aging animals subjected to sepsis [68] and may be down-
stream from endothelial dysfunction.
While we realize that the current model does not con-
sider all known pathophysiological processes of septic
shock (importantly, it does not fully consider inflamma-
tory/immune processes that are different in various
stages of the disease), the focus on cardiovascular events
may be justified, as prior studies have demonstrated that
cardiovascular failure is the primary cause of mortality
in the current model [69]. Therefore, our working hy-
pothesis may represent a useful 'working model', the ex-
perimental probing of which will require multiple lines
of additional studies. The current working model entails
potential therapeutic/interventional strategies, including
pharmacological approaches such as restoration of vas-
cular NO homeostasis, restoration of antioxidant defense
systems such as Nrf2 and various antioxidant/endothelial
protective/mitochondrial protective strategies.
Key messages
 eNOS deficiency and aging both exacerbated the
severity of sepsis.
 This is evidenced by increased oxidative stress,
MODS, and mortality.
 Vascular dysfunction is particularly severe in aged
animals subjected to sepsis, and precedes and
predicts mortality.
 We conclude that the lack of endothelial NO
production, on its own, is sufficient to markedly
exacerbate the severity of septic shock. Aging
markedly worsens the degree of endothelial
dysfunction in sepsis, yielding a significant
worsening of the overall outcome.Abbreviations
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